Document Type
Blog Post
Publication Date
12-11-2017
Disciplines
Nervous System Diseases
Digital USD Citation
Serbin, Kenneth P., "Ionis drug successfully reduces toxic Huntington’s disease protein, paving way for Phase 2 trial of effect on patients" (2017). At Risk for Huntington's Disease. 245.
https://digital.sandiego.edu/huntingtons/245
